Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I M Nilsson

Showing results (1-10 of 390) with videos related to

Pageof 39
Sort By:
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1980
Clinical pharmacology of aminocaproic and tranexamic acidsI M Nilsson
Acta Clinica Belgica|January 1, 1977
Synthetic activators of fibrinolysisI M Nilsson
Seminars in Hematology|April 1, 1988
Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF)I M Nilsson
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Fibrinogen degradation products and renal diseaseI M Nilsson
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
Coagulation and fibrinolysisI M Nilsson
Thrombosis and Haemostasis|June 30, 1976
Management of haemophilia in SwedenI M Nilsson
Lakartidningen|February 14, 1979
[Haemophilia]I M Nilsson
Transfusion Medicine Reviews|October 1, 1992
The management of hemophilia patients with inhibitorsI M Nilsson
Lakartidningen|December 23, 1981
[The situation of hemophiliacs in Sweden]I M Nilsson
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Determination of fibrinogen degradation products in serum and urine as a new diagnostic toolI M Nilsson
Pageof 39

Showing results (1-10 of 390) with videos related to

Sort By:
Pageof 39
Journal of Clinical Pathology. Supplement (Royal College of Pathologists)|January 1, 1980
Clinical pharmacology of aminocaproic and tranexamic acidsI M Nilsson
Acta Clinica Belgica|January 1, 1977
Synthetic activators of fibrinolysisI M Nilsson
Seminars in Hematology|April 1, 1988
Biochemical properties of Monoclate factor VIII:C antihemophilic factor (human) using monoclonal antibody to von Willebrand factor (VWF)I M Nilsson
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Fibrinogen degradation products and renal diseaseI M Nilsson
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
Coagulation and fibrinolysisI M Nilsson
Thrombosis and Haemostasis|June 30, 1976
Management of haemophilia in SwedenI M Nilsson
Lakartidningen|February 14, 1979
[Haemophilia]I M Nilsson
Transfusion Medicine Reviews|October 1, 1992
The management of hemophilia patients with inhibitorsI M Nilsson
Lakartidningen|December 23, 1981
[The situation of hemophiliacs in Sweden]I M Nilsson
Scandinavian Journal of Haematology. Supplementum|January 1, 1971
Determination of fibrinogen degradation products in serum and urine as a new diagnostic toolI M Nilsson
Pageof 39